Skip to main content
. 2015 May 20;6(22):19279–19289. doi: 10.18632/oncotarget.4220

Table 2. Patient 36, cell pathways altered on transcriptomic analyses comparing primary RCC with corresponding metastasis and the two xenografts derived from primary RCC.

Cell signaling pathway Number of genes with expression change p-value
GnRH 28 0.09
Cytosolic DNA 17 0.05
MAPK 70 0.04
p53 22 0.04